Autism Diagnostic Assessments With Children, Adolescents, and Adults Prior to and During the COVID-19 Pandemic: A Cross-Sectional Survey of Professionals.

COVID-19 pandemic autism autism diagnostic assessment innovation post-diagnostic support telehealth

Journal

Frontiers in psychiatry
ISSN: 1664-0640
Titre abrégé: Front Psychiatry
Pays: Switzerland
ID NLM: 101545006

Informations de publication

Date de publication:
2022
Historique:
received: 05 10 2021
accepted: 23 03 2022
entrez: 16 5 2022
pubmed: 17 5 2022
medline: 17 5 2022
Statut: epublish

Résumé

Access to timely high quality autism diagnostic assessments has traditionally been patchy; many individuals wait months, if not years, for an appointment. The onset of the COVID-19 pandemic has likely impacted autism diagnostic services. This study investigated professionals' experiences of, and thoughts about: (1) how autism diagnostic assessments were conducted before the pandemic; (2) adaptations to service provision because of the pandemic; and (3) challenges, risks, advantages and opportunities associated with autism assessments conducted Fifty-two professionals, based in different autism diagnostic services and working with children, adolescents and/or adults, completed an online cross-sectional survey in August and September 2020. This comprised demographic questions (about professionals' roles and experiences), and closed and open questions about service provision and telehealth autism assessments. There was substantial variation in how autism assessments were conducted prior to and during the pandemic; for example, in relation to the number of professionals involved in the assessment and types of structured, semi-structured and unstructured measures used to conduct this. Fifty-two percent of participants ( The pandemic has potentially compounded existing bottlenecks to the autism diagnostic pathway. Future research should seek to improve timeliness, standardization, accessibility and robustness of this pathway, and the validity and reliability of telehealth autism assessments.

Sections du résumé

Background UNASSIGNED
Access to timely high quality autism diagnostic assessments has traditionally been patchy; many individuals wait months, if not years, for an appointment. The onset of the COVID-19 pandemic has likely impacted autism diagnostic services. This study investigated professionals' experiences of, and thoughts about: (1) how autism diagnostic assessments were conducted before the pandemic; (2) adaptations to service provision because of the pandemic; and (3) challenges, risks, advantages and opportunities associated with autism assessments conducted
Method UNASSIGNED
Fifty-two professionals, based in different autism diagnostic services and working with children, adolescents and/or adults, completed an online cross-sectional survey in August and September 2020. This comprised demographic questions (about professionals' roles and experiences), and closed and open questions about service provision and telehealth autism assessments.
Results UNASSIGNED
There was substantial variation in how autism assessments were conducted prior to and during the pandemic; for example, in relation to the number of professionals involved in the assessment and types of structured, semi-structured and unstructured measures used to conduct this. Fifty-two percent of participants (
Conclusions UNASSIGNED
The pandemic has potentially compounded existing bottlenecks to the autism diagnostic pathway. Future research should seek to improve timeliness, standardization, accessibility and robustness of this pathway, and the validity and reliability of telehealth autism assessments.

Identifiants

pubmed: 35573336
doi: 10.3389/fpsyt.2022.789449
pmc: PMC9096098
doi:

Types de publication

Journal Article

Langues

eng

Pagination

789449

Informations de copyright

Copyright © 2022 Spain, Stewart, Mason, Robinson, Capp, Gillan, Ensum and Happé.

Déclaration de conflit d'intérêts

JR was employed by Cambridge Lifespan Autism Spectrum Service. NG was employed by Bristol Autism Spectrum Service. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

BMC Psychiatry. 2018 Jul 13;18(1):222
pubmed: 30005612
JAMA Pediatr. 2021 Jun 1;175(6):e210054
pubmed: 33779707
Health Policy Technol. 2020 Dec;9(4):673-691
pubmed: 32874853
Autism Res. 2021 Dec;14(12):2564-2579
pubmed: 34378858
Rev J Autism Dev Disord. 2021;8(4):454-470
pubmed: 34868805
Autism Res. 2021 Nov;14(11):2251-2259
pubmed: 34553489
Lancet Glob Health. 2020 Nov;8(11):e1364-e1365
pubmed: 32791119
Autism Res. 2012 Jun;5(3):160-79
pubmed: 22495912
Res Autism Spectr Disord. 2021 Oct;88:101859
pubmed: 34512797
PLoS One. 2020 Jul 23;15(7):e0236415
pubmed: 32702017
Clin Child Fam Psychol Rev. 2021 Sep;24(3):599-630
pubmed: 34114135
J Autism Dev Disord. 2022 May;52(5):2247-2257
pubmed: 34085153
Autism. 2021 Oct;25(7):2087-2100
pubmed: 34000858
Br J Gen Pract. 2017 Jun;67(659):e445-e452
pubmed: 28483821
Res Autism Spectr Disord. 2021 May;83:101747
pubmed: 36570074
Autism. 2019 May;23(4):1065-1072
pubmed: 30244604
J Child Psychol Psychiatry. 2021 Feb;62(2):140-142
pubmed: 32384166
Autism. 2020 Aug;24(6):1311-1327
pubmed: 32106698
J Child Psychol Psychiatry. 2022 Jun;63(6):674-682
pubmed: 34414570
Child Adolesc Ment Health. 2013 Feb;18(1):52-63
pubmed: 23539140
J Autism Dev Disord. 2018 Aug;48(8):2677-2691
pubmed: 29502151
J Autism Dev Disord. 2022 Dec;52(12):5383-5394
pubmed: 34914016
Eur Child Adolesc Psychiatry. 2016 Jul;25(7):769-80
pubmed: 26584575
Autism. 2016 Feb;20(2):153-62
pubmed: 25810370
Dev Neurorehabil. 2020 Oct;23(7):413-430
pubmed: 36112897
SAGE Open Med. 2021 Jul 17;9:20503121211031310
pubmed: 34349995
J Child Psychol Psychiatry. 2020 Mar;61(3):218-232
pubmed: 31994188
J Autism Dev Disord. 1994 Oct;24(5):659-85
pubmed: 7814313
Australas Psychiatry. 2015 Apr;23(2):120-3
pubmed: 25653302
J Autism Dev Disord. 2022 Jan;52(1):473-482
pubmed: 33689088
J Autism Dev Disord. 2022 Feb;52(2):962-973
pubmed: 33730320
Mol Autism. 2018 Mar 6;9:16
pubmed: 29541438
Psychopathology. 2017;50(3):219-227
pubmed: 28528329
Autism. 2018 Jul;22(5):517-527
pubmed: 28548543

Auteurs

Debbie Spain (D)

Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.

Gavin R Stewart (GR)

Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.

David Mason (D)

Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.

Janine Robinson (J)

Cambridge Lifespan Autism Spectrum Service, Cambridge, United Kingdom.

Simone J Capp (SJ)

Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.

Nicola Gillan (N)

Bristol Autism Spectrum Service, Bristol, United Kingdom.

Ian Ensum (I)

Bristol Autism Spectrum Service, Bristol, United Kingdom.

Francesca Happé (F)

Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.

Classifications MeSH